Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting

References

• World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization, 1994. Report no 843
   Google Scholar
• Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535–41
   PubMed Web of Science ®Google Scholar
• Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized, controlled trial. JAMA 1999;282:1344–52
   PubMed Web of Science ®Google Scholar
• Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688–703
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–41
   PubMed Web of Science ®Google Scholar
• Lundkvist J, Johnell O, Cooper C, Sykes D. Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Osteoporos Int 2006;17:201–11
   PubMed Web of Science ®Google Scholar
• Eli Lilly and Company. FORSTEO (teriparatide [rDNA origin] injection). Product label, 2006. Available from http://www.emea.eu.int/humandocs/Humans/EPAR/forsteo/forsteo.htm [Last accessed 26 Mar 2007]
   Google Scholar
• The EuroQol Group. EuroQoL – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208
   PubMed Web of Science ®Google Scholar
• Szende A, Williams A, editors. Measuring self-reported population health: an international perspective based on EQ-5D. ISBN 963 94 56 470. SpringMed Publishing Ltd, 2004
   Google Scholar
• Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int 2005;16:447–55
   PubMed Web of Science ®Google Scholar
• Brenneman SK, Barrett-Connor E, Sajjan S, et al. Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Miner Res 2006;21:809–16
   PubMed Web of Science ®Google Scholar
• Oleksik AM, Ewing S, Shen W, et al. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int 2005;16:861–70
   PubMed Web of Science ®Google Scholar
• Hallberg I, Rosenqvist AM, Kartous L, et al. Health-related quality of life after osteoporotic fractures. Osteoporos Int 2004;15:834–41
   PubMed Web of Science ®Google Scholar
• Adachi JD, Ioannidis G, Olszynski WP, et al. The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord 2002;3:11
   PubMed Web of Science ®Google Scholar
• de Oliveira PP, Klumb EM, Marinheiro LP. Prevalence of fracture risk estimated by quantitative ultrasound of the calcaneus in a population of postmenopausal women. Cad Saude Publica 2007;23:381–90
   Google Scholar
• Brooks R, Rabin R, de Charro F. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer Academic Publishers, 2003
   Google Scholar
• Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60:1571–82
   PubMed Web of Science ®Google Scholar
• de Vries M, Ouwendijk R, Kessels AG, et al. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 2005;41:261–8
   PubMed Web of Science ®Google Scholar
• Wasserfallen J-B, Halabi G, Saudan P, et al. Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 2004;19: 1594–9
   Google Scholar
• van Schoor NM, Smit JH, Twisk JWR, Lips P. Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int 2005;16:749–56
   PubMed Web of Science ®Google Scholar
• Silverman SL, Piziak VK, Chen P, et al. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 2005;32:2405–9
   PubMed Web of Science ®Google Scholar
• Cockerill W, Lunt M, Silman AJ, et al. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 2004;15:113–9
   PubMed Web of Science ®Google Scholar